Impeding Quorum Sensing Among the Intestinal Microbiota Impacts the Metastatic Rate of Colorectal Cancer
PMCID: PMC12177794
PMID: 40536191
DOI: 10.1002/cam4.71009
Journal: Cancer medicine
Publication Date: 2025-6-19
Authors: Dietz M, Gates TJ, Sikdar R, Subramanian S, Elias MH, et al.
Key Points
- QQ lactonase treatment demonstrated sex-specific effects on CRC metastasis
- Male mice treated with SsoPox showed 0% metastasis compared to 30% in control group
- Potential for developing novel CRC therapies targeting bacterial communication systems
Summary
This preclinical study investigated the role of quorum quenching (QQ) lactonases in colorectal cancer (CRC) metastasis, revealing striking sex-specific differences in treatment response. Using a mouse model of aggressive CRC with multiple genetic mutations, researchers found that QQ treatment with SsoPox enzyme dramatically reduced metastasis in male mice (0% metastasis) while paradoxically increasing metastatic potential in female mice (100% metastasis rate).
Notably, the QQ treatment minimally impacted the gut microbiome composition, inflammatory markers, and short-chain fatty acid production. The researchers hypothesize that the divergent responses may be linked to sex-specific endocrine interactions, potentially involving testosterone and estradiol levels, which could modulate bacterial quorum sensing and cancer progression. While the study is preliminary and limited by sample size, it suggests a promising avenue for developing targeted CRC therapies that exploit microbial communication mechanisms.